Avid Bioservices, Inc. - Common Stock (CDMO)
12.46
0.00 (0.00%)
Avid Bioservices Inc is a biotechnology company focused on providing comprehensive biomanufacturing solutions for the development and production of complex biologics, including monoclonal antibodies and other therapeutic proteins
The company serves a diverse range of clients, including pharmaceutical and biotechnology firms, by offering a wide array of services that encompass process development, scale-up, and cGMP (current Good Manufacturing Practice) production. Avid Bioservices is dedicated to advancing the field of biopharmaceuticals through its expertise in cell culture development and regulatory compliance, ultimately supporting the successful commercialization of innovative therapies for various diseases.
Previous Close | 12.46 |
---|---|
Open | - |
Bid | 12.46 |
Ask | 12.51 |
Day's Range | N/A - N/A |
52 Week Range | 5.900 - 12.48 |
Volume | 3 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 1,251,583 |
News & Press Releases
Avid Stockholders Approve Transaction with GHO and Ampersand
TUSTIN, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQCDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that Avid stockholders voted to approve the transaction with GHO Capital Partners LLP ("GHO") and Ampersand Capital Partners (“Ampersand”) at the Avid special meeting of stockholders (the “Special Meeting”) held earlier today.
By Avid Bioservices, Inc · Via GlobeNewswire · January 30, 2025
Avid Reminds Stockholders to Vote Today FOR the Transaction with GHO and Ampersand
Mails Letter to Stockholders Highlighting the Significant, Immediate and Certain Cash Value the Transaction Delivers to Stockholders
By Avid Bioservices, Inc · Via GlobeNewswire · January 22, 2025
Avid Recommends Stockholders Follow Recommendations of ISS and Glass Lewis and vote FOR the Transaction with GHO and Ampersand
Leading Independent Proxy Advisory Firms Recognize the Significant, Immediate and Certain Cash Value the Transaction Delivers to Avid Stockholders
By Avid Bioservices, Inc · Via GlobeNewswire · January 21, 2025
Avid Bioservices Files Investor Presentation Highlighting Value Maximizing Transaction with GHO and Ampersand
Avid Urges Stockholders to Vote FOR the Pending Transaction TODAY
By Avid Bioservices, Inc · Via GlobeNewswire · January 8, 2025
AVID BIOSERVICES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avid Bioservices, Inc. - CDMO
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Avid Bioservices, Inc. (NasdaqCM: CDMO) to funds managed by GHO Capital Partners LLP and Ampersand Capital Partners. Under the terms of the proposed transaction, shareholders of Avid will receive $12.50 in cash for each share of Avid that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
By Kahn Swick & Foti, LLC · Via Business Wire · January 6, 2025
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATSG, CDMO, ROIC, SUM on Behalf of Shareholders
NEW YORK, Jan. 05, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
By Halper Sadeh LLC · Via GlobeNewswire · January 5, 2025
Avid Bioservices Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by GHO and Ampersand
TUSTIN, Calif., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQCDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced the expiration of the waiting period under the Hart-Scott-Rodino (“HSR”) Antitrust Improvements Act of 1976 with respect to the previously announced agreement for Avid to be acquired by GHO Capital Partners LLP ("GHO") and Ampersand Capital Partners (“Ampersand”).
By Avid Bioservices, Inc · Via GlobeNewswire · December 30, 2024
CDMO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Avid Bioservices, Inc. Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Avid Bioservices, Inc. (NASDAQCDMO) to funds managed by GHO Capital Partners LLP and Ampersand Capital Partners for $12.50 per share in cash is fair to Avid shareholders.
By Halper Sadeh LLC · Via Business Wire · December 28, 2024
Avid Bioservices Recommends Stockholders Vote FOR Value Maximizing Transaction
Files Definitive Proxy Statement and Mails Letter to Stockholders
By Avid Bioservices, Inc · Via GlobeNewswire · December 18, 2024
Avid Bioservices, Inc. Is Being Investigated For Securities Law Violations And Affected Investors Are Invited To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / December 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Avid Bioservices, Inc. ("Avid" or "the Company") (NASDAQCDMO) for potential breaches of fiduciary duty on the part of its directors and management.
Via ACCESSWIRE · December 16, 2024
The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Avid Bioservices Inc For Securities Fraud
LOS ANGELES, CA / ACCESSWIRE / December 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Avid Bioservices, Inc. ("Avid" or "the Company") (NASDAQCDMO) for potential breaches of fiduciary duty on the part of its directors and management.
Via ACCESSWIRE · December 15, 2024
Avid Bioservices, Inc. Is Being Investigated For Securities Law Violations And Affected Investors Are Invited To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / December 14, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Avid Bioservices, Inc. ("Avid" or "the Company") (NASDAQCDMO) for potential breaches of fiduciary duty on the part of its directors and management.
Via ACCESSWIRE · December 14, 2024
The Schall Law Firm Urges Stockholder Participation In An Inquiry Into Avid Bioservices Inc For Possible Securities Fraud
LOS ANGELES, CA / ACCESSWIRE / December 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Avid Bioservices, Inc. ("Avid" or "the Company") (NASDAQCDMO) for potential breaches of fiduciary duty on the part of its directors and management.
Via ACCESSWIRE · December 13, 2024
Avid Bioservices, Inc. Is Being Investigated For Securities Related Infractions And Affected Investors Are Invited To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / December 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Avid Bioservices, Inc. ("Avid" or "the Company") (NASDAQCDMO) for potential breaches of fiduciary duty on the part of its directors and management.
Via ACCESSWIRE · December 12, 2024
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFIE, CDMO, RKDA on Behalf of Shareholders
NEW YORK, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
By Halper Sadeh LLC · Via GlobeNewswire · December 11, 2024
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CDMO, BRKH, CTV, EMKR on Behalf of Shareholders
NEW YORK, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
By Halper Sadeh LLC · Via GlobeNewswire · December 4, 2024
CDMO Investors Have the Opportunity to Join Investigation of Avid Bioservices, Inc. with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Avid Bioservices, Inc. (“Avid” or “the Company”) (NASDAQCDMO) for potential breaches of fiduciary duty on the part of its directors and management.
By The Schall Law Firm · Via Business Wire · December 2, 2024
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AE, CDMO, ALTR on Behalf of Shareholders
NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
By Halper Sadeh LLC · Via GlobeNewswire · November 21, 2024
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AE, ROIC, CDMO, EMKR on Behalf of Shareholders
NEW YORK, Nov. 16, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
By Halper Sadeh LLC · Via GlobeNewswire · November 16, 2024
AVID BIOSERVICES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avid Bioservices, Inc. - CDMO
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Avid Bioservices, Inc. (NasdaqCM: CDMO) to funds managed by GHO Capital Partners LLP and Ampersand Capital Partners. Under the terms of the proposed transaction, shareholders of Avid will receive $12.50 in cash for each share of Avid that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
By Kahn Swick & Foti, LLC · Via Business Wire · November 9, 2024
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CDMO, VINE, YOTA on Behalf of Shareholders
NEW YORK, Nov. 09, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
By Halper Sadeh LLC · Via GlobeNewswire · November 9, 2024
Shareholder Alert: Ademi LLP Investigates Whether Avid Bioservices, Inc. Is Obtaining a Fair Price for Its Public Shareholders
Ademi LLP is investigating Avid (NASDAQCDMO) for possible breaches of fiduciary duty and other violations of law in its transaction with GHO and Ampersand.
By Ademi LLP · Via Business Wire · November 8, 2024
CDMO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Avid Bioservices, Inc. Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Avid Bioservices, Inc. (NASDAQCDMO) to funds managed by GHO Capital Partners LLP and Ampersand Capital Partners for $12.50 per share in cash is fair to Avid shareholders.
By Halper Sadeh LLC · Via Business Wire · November 7, 2024
Hershey, Upwork And 3 Stocks To Watch Heading Into Thursdaybenzinga.com
Via Benzinga · November 7, 2024
Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction
TUSTIN, Calif. and LONDON and BOSTON, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQCDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, GHO Capital Partners LLP ("GHO") and Ampersand Capital Partners (“Ampersand”) today announced they have entered into a definitive merger agreement for Avid to be acquired by funds managed by GHO and Ampersand in an all-cash transaction valued at approximately $1.1 billion.
By Avid Bioservices, Inc · Via GlobeNewswire · November 6, 2024